Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Oxcarbazepine Prices, Demand and Supply Overview
2025
Base Year
2023-2025
Historical Period
2026-2027
Forecast Period
Market Overview
Oxcarbazepine prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 152.6/KG in Q1 to USD 161.8/KG by Q2 as firmer dibenzazepine ketone synthesis intermediate costs and recovering epilepsy focal seizure and trigeminal neuralgia formulation procurement reversed the brief Q1 2026 pricing correction. Globally, the average rose from USD 112.1/KG in Q1 to USD 118.8/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 116-130/KG is expected, with continued firming on Middle East supply disruptions and growing anticonvulsant, neuropathic pain, and bipolar mood stabiliser sector demand globally.
Oxcarbazepine is the 10-oxo keto analogue of carbamazepine, a second-generation dibenzazepine anticonvulsant synthesised through introduction of a 10-keto group at the 10,11-position of the dibenz[b,f]azepine ring system, yielding the 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide active pharmaceutical ingredient. Oxcarbazepine acts as a prodrug that is rapidly reduced by cytosolic arylketone reductase enzymes in the liver to the pharmacologically active S-licarbazepine monohydroxy metabolite responsible for voltage-gated sodium channel blockade. Compared to carbamazepine, oxcarbazepine and its active metabolite exhibit lower induction of cytochrome P450 enzyme systems, reducing drug-drug interactions and avoiding the autoinduction phenomenon that complicates carbamazepine dosing. The largest pull comes from epilepsy focal partial seizure treatment as monotherapy and adjunctive therapy in adults and paediatric patients, where published guidelines list it as a first- or second-line option. Trigeminal neuralgia, neuropathic pain, and bipolar disorder mood stabilisation add further demand. Improved paediatric tolerability and avoided autoinduction support steady prescribing growth globally. Dibenzazepine ketone synthesis intermediate costs, epilepsy and trigeminal neuralgia prescribing volumes, and regional API production capacity all feed into the price.
Oxcarbazepine Price Forecast for 2026
The balance of supply and demand for Oxcarbazepine through H2 2026 leans moderately firm. Synthesis intermediate costs firmed from Middle East chemical supply disruptions. Epilepsy focal seizure, trigeminal neuralgia, and bipolar disorder demand are growing with expanding neurological treatment access globally.
The main upside risk is synthesis intermediate cost increases alongside accelerating first-line epilepsy prescribing in developing markets. The main downside risk is eslicarbazepine acetate and newer antiepileptic competition and Chinese and Indian API surplus maintaining price pressure below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 116 - 130 | Synthesis cost firming and epilepsy/neuralgia/bipolar demand |
| United States | 124 - 138 | Steady epilepsy and trigeminal neuralgia demand holds firm |
| China | 83 - 97 | Large API capacity keeps it the most affordable |
| Germany | 154 - 168 | High synthesis and energy costs keep it the most expensive |
| India | 119 - 133 | Growing anticonvulsant and export demand holds a firm middle |
For the Quarter Ending June 2026
Oxcarbazepine Prices Q2 2026:
- United States: USD 132.4/KG
- China: USD 91.6/KG
- Germany: USD 161.8/KG
- India: USD 125.2/KG
Oxcarbazepine Prices in the United States
US Oxcarbazepine prices averaged USD 132.4/KG in Q2 2026, up 6.0% from USD 124.9/KG in Q1 2026. Firmer synthesis intermediate costs and recovering epilepsy and trigeminal neuralgia procurement drove consistent buying through the quarter.
Why did the price of Oxcarbazepine change in Q2 2026 in the United States?
Firmer dibenzazepine ketone synthesis intermediate costs raised the API production floor. Epilepsy focal seizure monotherapy and adjunctive, trigeminal neuralgia, and bipolar formulation procurement lifted buying. Neuropathic pain management demand provided additional support near USD 132.4/KG.
Oxcarbazepine Prices in China
Chinese Oxcarbazepine prices averaged USD 91.6/KG in Q2 2026, up 6.0% from USD 86.4/KG in Q1 2026, the lowest among the tracked markets. Spring epilepsy and neuralgia export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite large domestic API capacity.
Why did the price of Oxcarbazepine change in Q2 2026 in China?
Spring epilepsy and trigeminal neuralgia export and domestic procurement lifted buying. Firmer domestic synthesis intermediate costs raised the production floor. Large domestic API capacity kept China the most affordable source near USD 91.6/KG.
Oxcarbazepine Prices in Germany
German Oxcarbazepine prices averaged USD 161.8/KG in Q2 2026, up 6.0% from USD 152.6/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European production economics. Recovering epilepsy, trigeminal neuralgia, and bipolar demand maintained buying.
Why did the price of Oxcarbazepine change in Q2 2026 in Germany?
Higher dibenzazepine ketone synthesis and energy costs elevated European production economics. Middle East supply disruptions added cost premiums to synthesis chains. Recovering epilepsy, trigeminal neuralgia, and bipolar procurement maintained buying near USD 161.8/KG.
Oxcarbazepine Prices in India
Indian Oxcarbazepine prices averaged USD 125.2/KG in Q2 2026, up 6.0% from USD 118.1/KG in Q1 2026. Growing epilepsy, trigeminal neuralgia, and anticonvulsant export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Oxcarbazepine change in Q2 2026 in India?
Growing epilepsy and trigeminal neuralgia export and domestic procurement lifted buying. Firmer dibenzazepine synthesis import costs raised the floor. Bipolar and neuropathic pain export demand provided additional support near USD 125.2/KG.
For the Quarter Ending March 2026
Oxcarbazepine Prices Q1 2026:
- United States: USD 124.9/KG
- China: USD 86.4/KG
- Germany: USD 152.6/KG
- India: USD 118.1/KG
Oxcarbazepine Prices in the United States
US prices averaged USD 124.9/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-year-end epilepsy and neuralgia procurement moderation and soft synthesis costs eased the market before the Q2 spring recovery.
Why did the price of Oxcarbazepine change in Q1 2026 in the United States?
Post-year-end epilepsy and trigeminal neuralgia procurement moderation reduced buying urgency. Soft dibenzazepine synthesis costs eased the production floor. The market eased to USD 124.9/KG before the Q2 spring neurological season recovery.
Oxcarbazepine Prices in China
Chinese prices averaged USD 86.4/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-Lunar New Year epilepsy and neuralgia procurement moderation held the market near USD 86.4/KG.
Why did the price of Oxcarbazepine change in Q1 2026 in China?
Post-Lunar New Year epilepsy and neuralgia procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 86.4/KG before the Q2 spring neurological recovery.
Oxcarbazepine Prices in Germany
German prices averaged USD 152.6/KG in Q1 2026, easing about 2.1% from Q4 2025. Post-year-end epilepsy and bipolar procurement moderation and soft synthesis and energy costs eased the European market near USD 152.6/KG.
Why did the price of Oxcarbazepine change in Q1 2026 in Germany?
Post-year-end epilepsy and bipolar procurement moderation reduced urgency. Soft dibenzazepine synthesis and energy costs eased the floor. The market eased to USD 152.6/KG before the Q2 spring neurological season recovery.
Oxcarbazepine Prices in India
Indian prices averaged USD 118.1/KG in Q1 2026, easing about 1.9% from Q4 2025. Post-holiday epilepsy and neuralgia procurement moderation and soft synthesis import costs held the market near USD 118.1/KG.
Why did the price of Oxcarbazepine change in Q1 2026 in India?
Post-holiday epilepsy and trigeminal neuralgia procurement moderation reduced urgency. Soft dibenzazepine synthesis import costs eased the production floor. The market eased to USD 118.1/KG before the Q2 spring neurological recovery.
Quarterly Oxcarbazepine Price Trends
Global Oxcarbazepine prices firmed through Q3 and Q4 2025 on epilepsy and neuralgia treatment season demand, corrected in Q1 2026 on post-year-end moderation, then surged in Q2 2026. The average rose from USD 110.0/KG in Q2 2025 to USD 112.2/KG in Q3 and USD 114.4/KG in Q4, eased to USD 112.1/KG in Q1 2026, then surged to USD 118.8/KG in Q2 2026, a net gain of about 8.0% over the window. Dibenzazepine synthesis cost cycles and epilepsy, trigeminal neuralgia, and bipolar procurement drove the seasonal pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 118.8 | +6.0% | ↑ Rising |
| Q1 2026 | 112.1 | -2.0% | ↓ Falling |
| Q4 2025 | 114.4 | +2.0% | ↑ Rising |
| Q3 2025 | 112.2 | +2.0% | ↑ Rising |
| Q2 2025 | 110.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
What was Oxcarbazepine Price in 2025?
Oxcarbazepine prices firmed through 2025 on consistent epilepsy and trigeminal neuralgia demand. The global average opened near USD 105.8/KG in Q1 2025 and closed at USD 114.4/KG in Q4, a full-year gain of about 8.1%. Synthesis cost firming and epilepsy and neuralgia prescribing drove the upward trajectory throughout the year.
Oxcarbazepine Prices in the United States in 2025
US prices firmed from about USD 122.5/KG in Q1 2025 to USD 127.4/KG by Q4, a gain of 4.0%. Consistent epilepsy and trigeminal neuralgia demand maintained the upward trend.
Oxcarbazepine Prices in China in 2025
Chinese prices firmed from roughly USD 84.8/KG in Q1 2025 to USD 88.2/KG by Q4, a gain of 4.0%. Growing anticonvulsant export and domestic demand drove moderate firming.
Oxcarbazepine Prices in Germany in 2025
German prices firmed from about USD 149.6/KG in Q1 2025 to USD 155.7/KG by Q4, a gain of 4.1%. Consistent epilepsy, trigeminal neuralgia, and bipolar demand and firm synthesis costs supported the market.
Oxcarbazepine Prices in India in 2025
Indian prices firmed from roughly USD 115.8/KG in Q1 2025 to USD 120.5/KG by Q4, a gain of 4.1%. Growing anticonvulsant and essential medicine export demand drove consistent firming.
How We Can Help
Expert Market Research: Your Source for Real-Time Oxcarbazepine Price Intelligence
Expert Market Research tracks Oxcarbazepine prices continuously across every major producing and consuming region. The team traces causation through dibenzazepine ketone synthesis intermediate economics, epilepsy and trigeminal neuralgia prescription cycles, and regional API production capacity. Contact Expert Market Research today for Oxcarbazepine pricing data, bespoke market analysis, and strategic advisory.
Key Questions Answered in the Report
Epilepsy focal partial seizure treatment as monotherapy and adjunctive therapy in adults and paediatric patients, where published guidelines list it as a first- or second-line option with improved tolerability versus carbamazepine due to lower CYP450 enzyme induction and avoided autoinduction, takes the largest share. Trigeminal neuralgia and neuropathic pain management and bipolar disorder mood stabilisation also consume significant volumes globally.
The Q2 2026 average was USD 132.4/KG in the United States, USD 91.6/KG in China, USD 161.8/KG in Germany, and USD 125.2/KG in India. Germany remains the highest-priced market.
The global average rose from USD 112.1/KG in Q1 to about USD 118.8/KG in Q2, a gain of around 6.0%. Recovering epilepsy and trigeminal neuralgia demand and firmer synthesis costs drove the H1 recovery from the Q1 correction.
Post-year-end epilepsy and trigeminal neuralgia procurement moderation reduced buying urgency. Soft dibenzazepine synthesis costs eased the API production floor before the Q2 spring neurological season recovery.
The global average is expected in the USD 116 to 130/KG range for H2 2026, with continued firming as synthesis costs stay elevated and epilepsy, neuralgia, and bipolar demand grows.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on epilepsy and neuralgia demand, and China prices lowest on large domestic API capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to dibenzazepine ketone synthesis intermediate costs, epilepsy and trigeminal neuralgia prescribing cycles, and neurological treatment access expansion. Synthesis precursor prices and epilepsy prescribing volumes are key upstream signals.
China and India hold the largest oxcarbazepine API synthesis capacity. Any dibenzazepine synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time epilepsy and neuralgia formulation contracts around synthesis cost cycles, build cover when intermediate signals tighten, and monitor epilepsy prescribing volumes as the primary demand signal.
Basic Report -
One Time
Basic Report -
Annual Subscription
Detailed Report -
One Time
Detailed Report -
Annual Subscription
Basic Report -
One Time
USD 799
tax inclusive*
- PDF Format
- 2-Years Historical Price Data
- Basic Visualizations And Trend Analysis
- Price Forecast (Next 6 Months)
- Summary Of Factors Influencing Prices
- News And Developments
- Monthly Report Updates
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis
- Insights From Government Data And Industry Bodies
- Analyst Support For Additional Insights
Basic Report -
Annual Subscription
USD 3,499
tax inclusive*
- PDF Format
- 2-Years Historical Price Data
- Basic Visualizations And Trend Analysis
- Price Forecast (Next 6 Months)
- Summary Of Factors Influencing Prices
- News And Developments
- Monthly Report Updates
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis (Quarterly)
- Insights From Government Data And Industry Bodies
- Analyst Support For Additional Insights
Detailed Report -
One Time
USD 4,299
tax inclusive*
- PDF Format
- 3-Years Historical Price Data
- Advanced Visualizations And In-Depth Trend Analysis
- Price Forecast (Next 2 Years)
- Comprehensive Analysis Of Factors Influencing Prices
- News And Developments
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis
- Insights From Government Data And Industry Bodies
- Monthly Report Updates
- Analyst Support For Additional Insights
Detailed Report -
Annual Subscription
USD 7,999
tax inclusive*
- PDF Format
- 3-Years Historical Price Data
- Advanced Visualizations And In-Depth Trend Analysis
- Price Forecast (Next 2 Years)
- Comprehensive Analysis Of Factors Influencing Prices
- News And Developments
- Monthly Report Updates
- Macroeconomic Factors And Their Impact
- Supply-Demand Analysis
- Insights From Government Data And Industry Bodies
- Analyst Support For Additional Insights
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
